The performance of companies tied to iconic drugs like Viagra presents a challenging investment landscape . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the patent expiration in key markets has introduced considerable risk . Investors are now grappling with the consequences of lowe